drug
BYLVAY
updated 3mo agoby Ipsen SA
community read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
Trials studying BYLVAY
- phase3Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
- phase3Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
- phase3An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
- phase3Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
- phase3This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2
- —Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis
- phase3Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome
News(1)
- Ipsen’s Bylvay fails key trial in children with rare liver diseaseIpsen disclosed that Bylvay failed a Phase 3 study for biliary atresia, a serious liver disease that leads the bile ducts to become blocked in babies. Babies with the disease can get a Kasai proced…endpoints · 24d ago
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that